Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Delineation of Reducing Clinical Target Volume for Early-stage Nasopharyngeal

NCT03839602 is registered in ClinicalTrials.gov with Sun Yat-sen University as lead sponsor.

NCT NCT03839602
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03839602 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Delineation of Reducing Clinical Target Volume for Early-stage Nasopharyngeal
Lead sponsor
Sun Yat-sen University
Phase
Phase 2
Overall status
Completed
Start date
May 1, 2001
Completion date
January 1, 2018
Enrollment
103 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

early-stage nasopharyngeal carcinoma, intensity modulated radiation therapy, target volume delineation